Lv11
30 积分 2024-03-25 加入
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study
1小时前
已完结
Abstract GS01-05: Pembrolizumab + Olaparib vs Pembrolizumab + Chemotherapy After Induction With Pembrolizumab + Chemotherapy for Locally Recurrent Inoperable or Metastatic TNBC: Randomized Open-Label Phase 2 KEYLYNK-009 Study
3个月前
已关闭
Emerging roles of intratumor microbiota in cancer metastasis
3个月前
已完结
Selinexor in Combination with R-GDP for Patients with Relapsed/Refractory B-Cell Lymphoma: Final Results of 18 Patients Treated at RP2D of Selinexor in the Selinda Phase Ib Lysa Study
4个月前
已完结
The late adverse events of rituximab therapy – rare but there!
4个月前
已完结
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response
4个月前
已完结
Prognostic role of metabolic parameters (MTV and TLG) of staging PET/CT in the pediatric population with Hodgkin’s lymphoma: an open discussion
4个月前
已完结
A randomized trial of ibrutinib and R‐GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma
5个月前
已完结
Predicting outcomes in CNS lymphoma with ctDNA
6个月前
已完结
皖公网安备34019202002308
